{
  "id": 10411836,
  "title": "Addex Therapeutics H1 Net Loss Widens, Operating Loss Narrows; Advances GABAB PAM Cough Program",
  "url": "https://urgent.news/2026/09/28/addex-therapeutics-h1-net-loss-widens-operating-loss-narrows-advances",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-09-28T08:44:37.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/addex-therapeutics-h1-net-loss-widens-operating-loss-narrows-advances-gabab-pam-cough"
  },
  "original_language": "en",
  "account": null,
  "summary": "(RTTNews) - Addex Therapeutics Ltd. (ADXN, ADXN.SW) on Monday reported a wider net loss for the first half, while operating loss narrowed from last year on lower research and development expenses.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}